Bienvenidos al Grupo de Trabajo
AFinf

6.1. Ajuste de dosis de antimicrobianos en insuficiencia renal => Ajuste de dosis en situaciones especiales

6.1.1. Insuficiencia renal

• Anexo 1. Dosificación de fármacos en insuficiencia renal. Guías S.E.N. 2008.
• Azanza JR, García E, Sábada B y Manubens A. Uso de antimicrobianos en pacientes con insuficiencia renal o hepática. Enferm Infecc Microbiol Clin.2009;27(10):593–599
• The renal drug handbook. Caroline Ashley and Aileen Currie Third Edition.
• Antimicrobial Stewardship Program of Nebraska Medicine. Renal Dosage Adjustment Guidelines for Antimicrobials. Nebraska Medicine. 2018. p. 1–34. 

6.1.2. Obesidad

• Guillermo Serra Soler, Olga Delgado Sánchez, Iciar Martínez-López y Olatz Pérez-Rodríguez. Recomendaciones para la dosificación de fármacos en la obesidad mórbida. Med Clin (Barc). 2008;130(20):778-82.
• Janson B, Thursky K. Dosing of antibiotics in obesity. Curr Opin Infect Dis. 2012 Dec;25(6):634–49. 
• Association of Scottish Antimicrobial Pharmacists and Healthcare Improvement Scotland. How should antibiotics be dosed in obesity? 2017. p. 21. 

6.1.3. Técnicas de reemplazo renal

• London Health Sciences Centre. IV anti-infective medication dosing in continuous renal replacement therapy. Vol. 6. 2006. p. 6–7. 
• Alhabardi SM, Almoliki M, Almeshari A, Alammari M. Antimicrobial Dosing in Intermittent & Continuous Hemodialysis. Gaz Med Sci. 2021 May 22;2(3):8–9. 
• BCPRA Pharmacy and Formulary Committee. Common Oral Antimicrobial Therapy Dosage Adjustments For Renal Function. BC renal agency. 2017. p. 2. 

6.1.4. Técnicas de oxigenación extracorpórea

• Abdul-Aziz MH, Roberts JA. Antibiotic dosing during extracorporeal membrane oxygenation: does the system matter? Curr Opin Anaesthesiol. 2020 Feb;33(1):71–82. 

6.2. Administración de antimicrobianos

• Nau R, Blei C, Eiffert H. Intrathecal Antibacterial and Antifungal Therapies. Clin Microbiol Rev. 2020 Jun 17;33(3).
• Gorham J, Taccone FS, Hites M. How to Use Nebulized Antibiotics in Severe Respiratory Infections. Antibiotics [Internet]. 2023 Jan 28;12(2):267.
• Fica AC. Antibióticos intratecales en pacientes adultos. Rev Chil infectología. 2003;20(2):89–98. 
• Cañete Ramirez C, Terradas Campanario S, Hernández Campanario, JorgeCastells Lao Ge, López Cabezas Mc, Dávila Pousa C, Vila Clérigues Mn. Boletín informativo farmacotecnia - Preparaciones intratecales. Grupo de trabajo de Farmacotecnia de la Sociedad Española de Farmacia Hospitalaria. 2016. p. 1–12. 

6.3. Sellado de catéteres

• Chaves F, Garnacho-Montero J, del Pozo JL, Bouza E, Capdevila JA, de Cueto M, et al. Executive summary: Diagnosis and Treatment of Catheter-Related Bloodstream Infection: Clinical Guidelines of the Spanish Society of Clinical Microbiology and Infectious Diseases (SEIMC) and the Spanish Society of Intensive Care Medicine and Coronary Units. Enferm Infecc Microbiol Clin. 2018 Feb;36(2):112–9. 

6.4. Guías de práctica clínica de los principales síndromes infecciosos

• Sepsis. Evans L, Rhodes A, Alhazzani W, Antonelli M, Coopersmith CM, French C, Machado FR, Mcintyre L, Ostermann M, Prescott HC, Schorr C, Simpson S, Wiersinga WJ, Alshamsi F, Angus DC, Arabi Y, Azevedo L, Beale R, Beilman G, Belley-Cote E, Burry L, Cecconi M, Centofanti J, Coz Yataco A, De Waele J, Dellinger RP, Doi K, Du B, Estenssoro E, Ferrer R, Gomersall C, Hodgson C, Møller MH, Iwashyna T, Jacob S, Kleinpell R, Klompas M, Koh Y, Kumar A, Kwizera A, Lobo S, Masur H, McGloughlin S, Mehta S, Mehta Y, Mer M, Nunnally M, Oczkowski S, Osborn T, Papathanassoglou E, Perner A, Puskarich M, Roberts J, Schweickert W, Seckel M, Sevransky J, Sprung CL, Welte T, Zimmerman J, Levy M. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Intensive Care Med. 2021 Nov;47(11):1181-1247. doi: 10.1007/s00134-021-06506-y. Epub 2021 Oct 2. PMID: 34599691; PMCID: PMC8486643.
• Endocarditis - Habib G, Lancellotti P, Antunes MJ, Bongiorni MG, Casalta J-P, Del Zotti F, et al. 2015 ESC Guidelines for the management of infective endocarditis. Eur Heart J. 2015 Nov 21;36(44):3075–128.
• Meningitis - Van de Beek D, Cabellos C, Dzupova O, Esposito S, Klein M, Kloek AT, et al. ESCMID guideline: Diagnosis and treatment of acute bacterial meningitis. Van de Beek D, Cabellos C, Dzupova O, Esposito S, Klein M, Kloek AT, et al. ESCMID guideline: Diagnosis and treatment of acute bacterial meningitis. Clin Microbiol Infect. 2016;22:S. Clin Microbiol Infect. 2016;22:S37–62
• Neumonía - Metlay JP, Waterer GW, Long AC, Anzueto A, Brozek J, Crothers K, et al. Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America. Am J Respir Crit Care Med. 2019 Oct 1;200(7):e45–67. 
• VIH - https://gesida-seimc.org/category/guias-clinicas/
• SEIMC. https://www.seimc.org/documentos-cientificos/procedimientos-microbiologia

6.5. Monitorización farmacocinética antimicrobianos

• Kably B, Launay M, Derobertmasure A, Lefeuvre S, Dannaoui E, Billaud EM. Antifungal Drugs TDM: Trends and Update. Ther Drug Monit. 2022 Feb 1;44(1):166-197. doi: 10.1097/FTD.0000000000000952. PMID: 34923544.
• Abdul-Aziz MH, Alffenaar JC, Bassetti M, Bracht H, Dimopoulos G, Marriott D, Neely MN, Paiva JA, Pea F, Sjovall F, Timsit JF, Udy AA, Wicha SG, Zeitlinger M, De Waele JJ, Roberts JA; Infection Section of European Society of Intensive Care Medicine (ESICM); Pharmacokinetic/pharmacodynamic and Critically Ill Patient Study Groups of European Society of Clinical Microbiology and Infectious Diseases (ESCMID); Infectious Diseases Group of International Association of Therapeutic Drug Monitoring and Clinical Toxicology (IATDMCT); Infections in the ICU and Sepsis Working Group of International Society of Antimicrobial Chemotherapy (ISAC). Antimicrobial therapeutic drug monitoring in critically ill adult patients: a Position Paper. Intensive Care Med. 2020 Jun;46(6):1127-1153. doi: 10.1007/s00134-020-06050-1. Epub 2020 May 7. PMID: 32383061; PMCID: PMC7223855.Guilhaumou R, Benaboud S, Bennis Y, Dahyot-Fizelier C, Dailly E, Gandia P, Goutelle S, Lefeuvre S, Mongardon N, Roger C, Scala-Bertola J, Lemaitre F, Garnier M. Optimization of the treatment with beta-lactam antibiotics in critically ill patients-guidelines from the French Society of Pharmacology and Therapeutics (Société Française de Pharmacologie et Thérapeutique-SFPT) and the French Society of Anaesthesia and Intensive Care Medicine (Société Française d'Anesthésie et Réanimation-SFAR). Crit Care. 2019 Mar 29;23(1):104. doi: 10.1186/s13054-019-2378-9. PMID: 30925922; PMCID: PMC6441232
• Rybak MJ, Le J, Lodise TP, Levine DP, Bradley JS, Liu C, et al. Therapeutic monitoring of vancomycin for serious methicillin-resistant Staphylococcus aureus infections: A revised consensus guideline and review by the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatr. Am J Heal Pharm. 2020 May 19;77(11):835–64. 
• Lin B, Hu Y, Xu P, Xu T, Chen C, He L, et al. Expert consensus statement on therapeutic drug monitoring and individualization of linezolid. Front Public Heal. 2022 Aug 10;10. 
• Nau R, Sörgel F, Eiffert H. Penetration of Drugs through the Blood-Cerebrospinal Fluid/Blood-Brain Barrier for Treatment of Central Nervous System Infections. Clin Microbiol Rev. 2010 Oct;23(4):858–83. 
• Goycochea-Valdivia WA, Melendo Pérez S, Aguilera-Alonso D, Escosa-Garcia L, Martínez Campos L, Baquero-Artigao F. Posicionamiento de la Sociedad Española de Infectología Pediátrica sobre la implementación, ejecución y monitorización de los programas de optimización de uso de antimicrobianos en pediatría hospitalaria. An Pediatría. 2022 Nov;97(5):351.e1-351.e12.

6.6. PROA

• Cercenado E, Rodríguez-Baño J, Alfonso JL, Calbo E, Escosa L, Fernández-Polo A, García-Rodríguez J, Garnacho J, Gil-Navarro MV, Grau S, Gudiol C, Horcajada JP, Larrosa N, Martínez C, Molina J, Nuvials X, Oliver A, Paño-Pardo JR, Pérez-Rodríguez MT, Ramírez P, Rey-Biel P, Vidal P, Retamar-Gentil P. Antimicrobial stewardship in hospitals: Expert recommendation guidance document for activities in specific populations, syndromes and other aspects (PROA-2) from SEIMC, SEFH, SEMPSPGS, SEMICYUC and SEIP. Enferm Infecc Microbiol Clin (Engl Ed). 2023 Jan 5:S2529-993X(22)00302-1. doi: 10.1016/j.eimce.2022.05.013.
• Normativa formación equipos PROA hospitalarios: https://www.resistenciaantibioticos.es/sites/default/files/2023-02/Norma%20de%20certificacion%20equipos%20PROA_Hospitalario.pdf
• Normativa formación equipos PROA comunitarios: https://resistenciaantibioticos.es/sites/default/files/2023-02/Norma%20de%20certificacion%20equipos%20PROA_Comunitarios.pdf